Literature DB >> 1846522

Chest wall involvement by lung cancer: computed tomographic detection and results of operation.

G B Ratto1, G Piacenza, C Frola, F Musante, I Serrano, R Giua, M Salio, P Jacovoni, S Rovida.   

Abstract

The aim of this prospective study was to evaluate: (1) the role of computed tomographic scanning in predicting chest wall invasion by peripheral lung cancer and (2) the results of operation according to the depth of chest wall involvement and other potential indicators of long-term survival. One hundred twelve patients with non-small cell lung cancer adjacent to the pleural surface who underwent computed tomographic scanning and subsequent thoracotomy were entered into this study. Tumor invasion was confined to the visceral pleura in 53 patients, to the parietal pleura in 18 patients, and to intercostal muscles in 25 patients; invasion extended beyond this layer in 16 patients. The computed tomographic criteria for chest wall invasion were (1) obliteration of the extrapleural fat plane, (2) the length of the tumor-pleura contact, (3) the ratio between the tumor-pleura contact and the tumor diameter, (4) the angle of the tumor with the pleura, (5) a mass involving the chest wall, and (6) rib destruction. The computed tomographic criteria 1 and 3 were significantly related to pathologic findings. Sensitivity was 85% for criterion 1 and 83% for criterion 3, specificity being 87% and 80%, respectively. Long-term survival of patients with T3 disease critically depended on the lymph node state and completeness of resection. The adenocarcinoma cell type and the T4 category were unfavorable prognostic factors. The depth of chest wall invasion did not affect survival, except for extensive rib and soft tissue infiltration. En bloc resection yielded better results than discontinuous resection.

Entities:  

Mesh:

Year:  1991        PMID: 1846522     DOI: 10.1016/0003-4975(91)90778-o

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

2.  Classification of parietal pleural invasion at adhesion sites with surgical specimens of lung cancer and implications for prognosis.

Authors:  Yukitoshi Satoh; Yuichi Ishikawa; Kentaro Inamura; Sakae Okumura; Ken Nakagawa; Eiju Tsuchiya
Journal:  Virchows Arch       Date:  2005-09-21       Impact factor: 4.064

3.  Preoperative computed tomographic scanning for staging lung cancer.

Authors:  P Armstrong
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

4.  Evaluation of new TNM lung cancer classification.

Authors:  Y Saito; Y Yamakawa; M Kiriyama; I Fukai; S Kondo; T Yano; T Yokoyama; M Tanahashi; Y Nakashima; Y Fujii
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-08

Review 5.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

6.  Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer.

Authors:  Paul J Speicher; Brian R Englum; Asvin M Ganapathi; Mark W Onaitis; Thomas A D'Amico; Mark F Berry
Journal:  Eur J Cardiothorac Surg       Date:  2014-07-08       Impact factor: 4.191

7.  Risk factors of chest wall invasion in non-small cell lung cancer.

Authors:  Nozomu Motono; Shun Iwai; Aika Yamagata; Yoshihito Iijima; Katsuo Usuda; Sohsuke Yamada; Hidetaka Uramoto
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

8.  Advances in radiological staging of non-small cell lung cancer (NSCLC).

Authors:  S C Rankin
Journal:  Cancer Imaging       Date:  2004-02-14       Impact factor: 3.909

9.  Staging of non-small cell lung cancer (NSCLC).

Authors:  S C Rankin
Journal:  Cancer Imaging       Date:  2006-01-31       Impact factor: 3.909

Review 10.  Staging non-small cell lung cancer.

Authors:  Leslie Eisenbud Quint
Journal:  Cancer Imaging       Date:  2007-10-22       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.